HIGHLIGHTS
- who: April and collaborators from the Zhejiang University, China have published the article: Real-world effects of once-daily inhaled steroid ( fl uticasone furoate) combined with long-acting beta-2 agonist (vilanterol) and long-acting muscarinic antagonist (umeclidinium) on lung function tests of asthma patients in Japan, in the Journal: (JOURNAL) of 18/02/2021
- what: The main reason why subjects preferred FF/UMEC/VI 200/62.5/ 25 u03bcg was a more powerful effect on asthma compared with previous drugs .
- how: All data were compared with the previous study of FF/VI . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.